These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12501826)

  • 1. Fat wasting--AZT vs. d4T.
    TreatmentUpdate; 2002 Nov; 14(8):6. PubMed ID: 12501826
    [No Abstract]   [Full Text] [Related]  

  • 2. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.
    Saint-Marc T; Partisani M; Poizot-Martin I; Bruno F; Rouviere O; Lang JM; Gastaut JA; Touraine JL
    AIDS; 1999 Sep; 13(13):1659-67. PubMed ID: 10509567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
    J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of zidovudine, stavudine and beta-aminoisobutyric acid on lipid homeostasis in mice: possible role in human fat wasting.
    Maisonneuve C; Igoudjil A; Begriche K; Lettéron P; Guimont MC; Bastin J; Laigneau JP; Pessayre D; Fromenty B
    Antivir Ther; 2004 Oct; 9(5):801-10. PubMed ID: 15535418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New questions about an old combination--ddI + d4T.
    Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.
    Mallal SA; John M; Moore CB; James IR; McKinnon EJ
    AIDS; 2000 Jul; 14(10):1309-16. PubMed ID: 10930144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
    Koh MT
    Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
    [No Abstract]   [Full Text] [Related]  

  • 8. Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
    Justice AC; Stein DS; Fusco GP; Sherrill BH; Fusco JS; Danehower SC; Becker SL; Hansen NI; Graham NM;
    J Clin Epidemiol; 2004 Jan; 57(1):89-97. PubMed ID: 15019015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects and complications. Does switching therapy away from d4T help the face?
    TreatmentUpdate; 2005 Dec; 17(7):2-3. PubMed ID: 17223668
    [No Abstract]   [Full Text] [Related]  

  • 10. d4T and lactic acidosis with neuromuscular weakness: FDA warning.
    AIDS Treat News; 2002 Mar; (378):5-6. PubMed ID: 11965919
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipoatrophy, fat accumulation, and mixed syndrome in protease inhibitor-naive HIV-infected patients.
    Polo R; Verdejo J; Martinez-Rodriguez S; Madrigal P; Gonzalez-Muñoz M
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):284-6. PubMed ID: 11115961
    [No Abstract]   [Full Text] [Related]  

  • 12. Side effects. FDA issues warning about d4T and ddI during pregnancy.
    TreatmentUpdate; 2001; 12(8):6-7. PubMed ID: 12132441
    [No Abstract]   [Full Text] [Related]  

  • 13. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.
    Nolan D; Hammond E; James I; McKinnon E; Mallal S
    Antivir Ther; 2003 Dec; 8(6):617-26. PubMed ID: 14760896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 15. New uses for tenofovir: more questions about d4T.
    Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa.
    Stead D; Osler M; Boulle A; Rebe K; Meintjes G
    Antivir Ther; 2008; 13(7):937-43. PubMed ID: 19043928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy.
    Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
    HIV Med; 2008 May; 9(5):317-21. PubMed ID: 18331562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipodystrophy and long-term therapy with nucleoside reverse transcriptase inhibitors.
    Moreno S; Martínez E
    AIDS; 2000 May; 14(7):905-6. PubMed ID: 10839605
    [No Abstract]   [Full Text] [Related]  

  • 19. Stavudine (Zerit).
    Res Initiat Treat Action; 2000 Mar; 6(1):12-3. PubMed ID: 11708176
    [No Abstract]   [Full Text] [Related]  

  • 20. It's time to face the Zerit problem.
    Vergel N
    GMHC Treat Issues; 2003 Mar; 17(3):12. PubMed ID: 12728861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.